Technical Analysis for TARA - ArTara Therapeutics, Inc.

Grade Last Price % Change Price Change
F 9.01 3.80% 0.33
TARA closed up 3.8 percent on Friday, May 14, 2021, on 72 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical TARA trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 3.80%
New 52 Week Low Weakness 3.80%
Wide Bands Range Expansion 3.80%
Oversold Stochastic Weakness 3.80%
New 52 Week Closing Low Bearish 2.50%
180 Bearish Setup Bearish Swing Setup 2.50%
Narrow Range Bar Range Contraction 2.50%
NR7 Range Contraction 2.50%
Older End-of-Day Signals for TARA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% about 22 hours ago
Rose Above Previous Day's High about 23 hours ago
60 Minute Opening Range Breakout about 24 hours ago
Up 3% 1 day ago
Up 2% 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ArTara Therapeutics, Inc., a clinical-stage company, develops product candidates for patients suffering from rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. The company's lead program is TARA-002, a cellular therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. ArTara Therapeutics, Inc. is based in New York, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Rare Diseases Gastrointestinal Chloride Lipid Vitamins Liver Disease Hepatology Metabolic Disorders Choline Cholinergics Connective Tissue Treatment Of Rare Diseases

Is TARA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 67.079
52 Week Low 8.54
Average Volume 146,207
200-Day Moving Average 19.24
50-Day Moving Average 14.06
20-Day Moving Average 11.31
10-Day Moving Average 9.61
Average True Range 0.81
ADX 39.74
+DI 10.21
-DI 35.56
Chandelier Exit (Long, 3 ATRs ) 14.80
Chandelier Exit (Short, 3 ATRs ) 10.98
Upper Bollinger Band 15.58
Lower Bollinger Band 7.04
Percent B (%b) 0.23
BandWidth 75.57
MACD Line -1.69
MACD Signal Line -1.56
MACD Histogram -0.1263
Fundamentals Value
Market Cap 101.02 Million
Num Shares 11.2 Million
EPS -30.61
Price-to-Earnings (P/E) Ratio -0.29
Price-to-Sales 0.00
Price-to-Book 1.34
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.67
Resistance 3 (R3) 9.64 9.39 9.56
Resistance 2 (R2) 9.39 9.22 9.41 9.52
Resistance 1 (R1) 9.20 9.12 9.30 9.23 9.49
Pivot Point 8.95 8.95 9.00 8.97 8.95
Support 1 (S1) 8.76 8.78 8.86 8.79 8.53
Support 2 (S2) 8.51 8.68 8.53 8.50
Support 3 (S3) 8.32 8.51 8.46
Support 4 (S4) 8.35